Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,789 | 3,770 | 29 | 64 |
| Receivables | 3 | N/A | N/A | N/A |
| Inventories | 160 | N/A | N/A | N/A |
| Other current assets | 107 | 114 | 0 | 5 |
| TOTAL | $4,825 | $4,650 | $29 | $70 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 739 | 1,552 | 120 | 166 |
| TOTAL | $739 | $1,552 | $120 | $166 |
| Total Assets | $5,564 | $6,202 | $149 | $236 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 639 | 397 | 546 | 527 |
| Accrued Expenses | 1,437 | 1,416 | 1,650 | 4,245 |
| TOTAL | $7,396 | $2,009 | $5,772 | $7,261 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 1 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 21 | 178 | 120 |
| TOTAL | $N/A | $21 | $178 | $120 |
| Total Liabilities | $7,396 | $2,030 | $5,950 | $7,380 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 36,281 | 33,104 | N/A | N/A |
| Common Shares | 3 | 3 | 3 | 3 |
| Retained earnings | -34,667 | -26,022 | -23,583 | -18,799 |
| TOTAL | $-1,832 | $4,172 | $-5,801 | $-7,144 |
| Total Liabilities And Equity | $5,564 | $6,202 | $149 | $236 |